Replies to post #21858 on Relief Therapeutics Holding AG (RLFTF)

[djhfsu]

Yes...can confirm the following from presentation:

19 of 21 aviptadil-treated patients survived
8 of 30 Maximum Standard of care (MSOC) control patients survived
90% vs. 27%; P<.001

The Yahoo poster info is accurate. Also, to your other question:

The emergency use application (EUA) for the patients in the worst situation (no medical alternative) was filed on 09/17. Also, results for Phase3 IV expected within a month.

Dave